Authentication Results Delivered and Suspects
Convicted in Record Time
Applied DNA Sciences, Inc. (NASDAQ: APDN, “Applied DNA” ), is
pleased to report that SigNature DNA evidence has resulted in two
new convictions, bringing the company’s total to 117.
Shaun Howard and his son Charlie Howard both pleaded guilty at
Woolwich Crown Court (London, United Kingdom) in January 2018 and
were convicted and sentenced to a total of 8 years
imprisonment.
The father-son team committed a cash-in-transit attack against
Loomis UK Limited on December 28, 2017, where they took possession
of a cash box containing approximately £10,000 (USD equivalent
$14,000). The criminals escaped in a van belonging to Shaun
Howard.
They did not realize that the box also contained a security ink
inoculated with SigNature DNA. Thanks to quick detective work and
Automatic Number Plate Recognition (ANPR) technology, police were
able to track the van and arrest the suspects.
Detectives collected evidential samples of ink stains from the
suspects, which were analyzed by Applied DNA’s forensic
laboratories. Within 5 working days, Kent Police received an Expert
Witness report from Applied DNA that forensically linked the
samples to the robbery. Nearly all of the stolen cash was
recovered.
“The evidence Applied DNA has provided was invaluable and
obviously assisted with the defendants entering early guilty pleas,
saving time and money,” commented Detective Constable David Bull
from Kent Police Serious Crime Directorate.
Tony Benson, Managing Director EMEA, added “This is the quickest
conviction I have ever heard of using our SigNature DNA evidence.
The number of days elapsed from the date of robbery to the
criminals being sentenced was only 29, and let’s not forget
Christmas and New Year holidays fell within this timeframe. This
outcome is the result of excellent teamwork by police, Loomis and
our forensic experts.”
This news comes hot on the heels of another conviction issued in
late 2017. Clement O’Doherty was charged with handling stolen cash
containing SigNature DNA, and was subsequently sentenced to 18
months for his role in a Loomis robbery at a London Tesco store in
February 2017. On the same day, Mr. O’Doherty was given an
additional 8 year sentence for grievous bodily harm inflicted in an
unrelated case.
SigNature DNA evidence has helped to convict 117 criminals to
date, with total sentences of over 550 years and many more cases in
the pipeline.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics.
We make life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. The proprietary DNA-based
“CertainT®” platform can be used to identify, tag, test, and track
products, to help assure authenticity, origin, traceability,
sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is
at the heart of a family of uncopyable, security and authentication
solutions such as SigNature® T and fiberTyping®, targeted toward
textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and
loss prevention, and digitalDNA®, providing powerful
track-and-trace. All provide a forensic chain of evidence, and can
be used to prosecute perpetrators. Applied DNA Sciences is also
engaged in the large-scale production of specific DNA sequences
using the polymerase chain reaction.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under the symbol
APDN, and its warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe APDN’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in APDN’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
28, 2017, which is available at www.sec.gov. APDN undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date
hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180202005306/en/
Investor:LHA Investor RelationsSanjay M. Hurry,
212-838-3777shurry@lhai.comorMedia:Dian Griesel Int’lCheryl
Schneider,
212-825-3210cschneider@dgicomm.comorProgram:Applied DNA
EuropeTony Benson, +1 44 (0) 7552 429341Managing
Directortony.benson@adnas.comorweb:
www.adnas.comtwitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024